FrancophonIA/ELRC3.0 huggingface dataset:
English: Co-administration of tenofovir disoproxil and didanosine results in a 40-60% increase in systemic exposure to didanosine that may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af tenofovirdisoproxil og didanosin resulterer i en 40-60% stigning i systemisk eksponering for didanosin, hvilket kan øge risikoen for didanosin-relaterede bivirkninger (se pkt.
English: + Raltegravir (400 mg b.i.d) + Emtricitabine/Tenofovir disoproxil (200 mg/245 mg q.d.)
Danish: + Raltegravir (400 mg b.i.d) + Emtricitabin/ tenofovirdisoproxil (200 mg/245 mg q.d.)
English: Pharmacokinetic parameters of tenofovir were determined following administration of a single dose of tenofovir disoproxil 245 mg to 40 non-HIV, non-HBV infected adult patients with varying degrees of renal impairment defined according to baseline adult creatinine clearance (CrCl) (normal renal function when CrCl > 80 ml/min; mild with CrCl = 50-79 ml/min; moderate with CrCl = 30-49 ml/min and severe with CrCl = 10-29 ml/min).
Danish: Farmakokinetiske parametre af tenofovir blev bestemt efter administration af en enkelt dosis af 245 mg tenofovirdisoproxil til 40 voksne patienter uden hiv- eller HBV-infektion med forskellige grader af nedsat nyrefunktion defineret i henhold til kreatininclearance (CrCl) hos voksne ved baseline (normal nyrefunktion med CrCl > 80 ml/min; let nedsat nyrefunktion med CrCl = 50-79 ml/min; moderat nedsat nyrefunktion med CrCl = 30-49 ml/min og svært nedsat nyrefunktion med CrCl = 10-29 ml/min).
English: Tenofovir exposure in HBV infected paediatric patients 2 to < 12 years of age receiving an oral daily dose of tenofovir disoproxil 6.5 mg/kg of body weight (tablet or granules) up to a maximum dose of 245 mg was similar to exposures achieved in HIV-1 infected paediatric patients 2 to <12 years of age receiving a once daily dose of tenofovir disoproxil 6.5 mg/kg up to a maximum dose of tenofovir disoproxil 245 mg.
Danish: Tenofovir-eksponeringen hos HBV-inficerede pædiatriske patienter i alderen 2 til < 12 år i behandling med en oral, daglig dosis tenofovirdisoproxil på 6,5 mg/kg af kropsvægten (tablet eller granulat) op til en maksimal dosis på 245 mg var sammenlignelig med de eksponeringer, der blev opnået hos hiv 1inficerede pædiatriske patienter i alderen 2 til < 12 år i behandling med tenofovirdisoproxil 6,5 mg/kg en gang dagligt op til en maksimal dosis tenofovirdisoproxil på 245 mg.
English: The following pack sizes are available: outer cartons containing 1 bottle of 30 film-coated tablets and 3 bottles of 30 film-coated tablets.
Danish: Fås i pakninger, der indeholder 1 tabletbeholder med 30 filmovertrukne tabletter eller 3 tabletbeholdere a 30 filmovertrukne tabletter.
English: Viread 163 mg film-coated tablets are white, round-shaped, film-coated tablets, 10.7 mm in diameter, debossed on one side with “GSI” and on the other side with “200”.
Danish: Viread 163 mg filmovertrukne tabletter er hvide, runde, filmovertrukne tabletter, der måler 10,7 mm i diameter, præget med „GSI“ på den ene side og „200“ på den anden side.
English: Viread 123 mg tablets are only suitable for:
Danish: Viread 123 mg tabletter er kun egnede til:
English: Viread 204 mg film-coated tablets are indicated for the treatment of chronic hepatitis B in paediatric patients aged 6 to < 12 years who weigh from 28 kg to less than 35 kg, with:
Danish: Viread 204 mg filmovertrukne tabletter er indiceret til behandling af kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 28 kg og under 35 kg med:
English: Viread 204 mg film-coated tablets are white, capsule-shaped, film-coated tablets, of dimensions 15.4 mm x 7.3 mm, debossed on one side with “GSI” and on the other side with “250”.
Danish: Viread 204 mg filmovertrukne tabletter er hvide, kapselformede, filmovertrukne tabletter, der måler 15,4 mm x 7,3 mm, præget med „GSI“ på den ene side og „250“ på den anden side.
English: This is to make sure that their medicine is fully effective, and to reduce the risk of developing resistance to the treatment.
Danish: Deres barn skal altid tage den dosis, Deres barns læge har anbefalet for at sikre, at medicinen er så effektiv som muligt og for at reducere udviklingen af resistens mod behandlingen.
English: Viread 245 mg tablets are a treatment for HIV (Human Immunodeficiency Virus) infection.
Danish: Viread 245 mg tabletter anvendes til behandling af infektion med hiv (humant immundefektvirus).
English: Before starting treatment, your child's doctor may order blood tests to assess your child's kidney function.
Danish: Før Deres barn påbegynder behandlingen, kan Deres barns læge bestille blodprøver for at bedømme Deres barns nyrefunktion Deres barns læge kan også bestille blodprøver under behandlingen for at overvåge, hvordan Deres barns nyrer fungerer.
English: • For HIV, Viread 163 mg tablets are only suitable for children who have already been treated with other HIV medicines which are no longer fully effective due to development of resistance, or have caused side effects.
Danish: • Til hiv er Viread 163 mg tabletter kun egnede til børn, der allerede er blevet behandlet med anden hiv-medicin, der ikke længere er helt effektivt på grund af udvikling af resistens, eller der forårsagede bivirkninger.
English: Whole body BMD at least 4% decrease
Danish: Mindst 4% fald i BMD for hele kroppen n/a n/a
English: By intent to treat analysis (missing data and switch in antiretroviral therapy (ART) considered as failure), the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml at 48 weeks of treatment was 80% and 76% respectively in the tenofovir disoproxil 245 mgarm, compared to 84% and 80% in the stavudine arm. At 144 weeks, the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml was 71% and 68% respectively in the tenofovir disoproxil 245 mgarm, compared to 64% and 63% in the stavudine arm.
Danish: Ved behandlingsintentionsanalyse (manglende data og skift i antiretroviral behandling (ART) blev betragtet som svigt) var procentdelen af patienter med hiv 1-rna under 400 kopier/ml og 50 kopier/ml i uge 48 af behandlingen henholdsvis 80% og 76% i 245 mg tenofovirdisoproxil behandlingsarmen, sammenlignet med 84% og 80% i stavudin behandlingsarmen.
English: INFORMATION IN BRAILLE Viread 204 mg [Outer packaging only]
Danish: Viread 204 mg [kun på den ydre emballage]
English: Viread 33 mg/g granules are also a treatment for chronic hepatitis B, an infection with HBV (hepatitis B virus).
Danish: Viread 33 mg/g granulat anvendes også til behandling af kronisk hepatitis B, som er en infektion med HBV (hepatitis B-virus).
English: The recommended dose for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 28 kg to < 35 kg who are able to swallow film-coated tablets is one 204 mg tablet once daily taken orally with food.
Danish: Den anbefalede dosis til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 28 kg og < 35 kg, og som er i stand til at sluge filmovertrukne tabletter, er én 204 mg tablet en gang dagligt taget oralt sammen med mad.
English: The following side effects are very common (these can affect at least 10 in every 100 patients):
Danish: Følgende bivirkninger er meget almindelige (kan opstå hos mere end 10 ud af 100 patienter):
English: Viread 163 mg tablets are a treatment for HIV (Human Immunodeficiency Virus) infection.
Danish: Viread 163 mg tabletter anvendes til behandling af infektion med hiv (humant immundefektvirus).
English: Table 9: Bone Mineral Density Evaluation at Baseline and Week 48
Danish: Tabel 9: Vurdering af knoglemineraltæthed ved baseline og uge 48
English: In a paediatric study (GS-US-174-0115), 52 patients (including 6 patients with lamivudine resistance mutations at baseline) initially received blinded tenofovir disoproxil for up to 72 weeks and then 51/52 patients switched to open-label tenofovir disoproxil (TDF-TDF group).
Danish: I et pædiatrisk studie (GS-US-174-0115) fik 52 patienter (herunder 6 patienter med lamivudinresistente mutationer ved baseline) indledningsvist blindet tenofovirdisoproxil i op til 72 uger, og derefter skiftede 51/52 patienter over til open-label tenofovirdisoproxil (TDF-TDF-gruppen).
English: Each tablet contains 109 mg lactose (as monohydrate).
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver tablet indeholder 109 mg lactose (som monohydrat).
English: White, capsule-shaped, film-coated tablets, of dimensions 15.4 mm x 7.3 mm, debossed on one side with “GSI” and on the other side with “250”.
Danish: Hvide, kapselformede, filmovertrukne tabletter, der måler 15,4 mm x 7,3 mm og er præget med „GSI“ på den ene side og „250“ på den anden.
English: Then mix the powder with about 100 ml (half a glass) of water, orange juice or grape juice and drink immediately.
Danish: Hvis De har særlige problemer med at synke, kan De knuse tabletten med spidsen af en ske og opløse den i ca. 100 ml (et halvt glas) vand, appelsinjuice eller druesaft.
English: INFORMATION IN BRAILLE Viread 123 mg [Outer packaging only]
Danish: Viread 123 mg [kun på den ydre emballage]
English: • For HIV, Viread 204 mg tablets are only suitable for children who have already been treated with other HIV medicines which are no longer fully effective due to development of resistance, or have caused side effects.
Danish: • Til hiv er Viread 204 mg tabletter kun egnede til børn, der allerede er blevet behandlet med anden hiv-medicin, der ikke længere er helt effektivt på grund af udvikling af resistens, eller der forårsagede bivirkninger.
English: The recommended dose for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 22 kg to < 28 kg who are able to swallow film-coated tablets is one 163 mg tablet once daily taken orally with food.
Danish: Den anbefalede dosis til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 22 kg og < 28 kg, og som er i stand til at sluge filmovertrukne tabletter, er én 163 mg tablet en gang dagligt taget oralt sammen med mad.
English: Each tablet contains 164 mg lactose (as monohydrate).
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver tablet indeholder 164 mg lactose (som monohydrat).
English: The recommended dose for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 6 to < 12 years weighing 17 kg to < 22 kg who are able to swallow film-coated tablets is one 123 mg tablet once daily taken orally with food.
Danish: Den anbefalede dosis til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 17 kg og < 22 kg, og som er i stand til at sluge filmovertrukne tabletter, er én 123 mg tablet en gang dagligt taget oralt sammen med mad.
English: NAME OF THE MEDICINAL PRODUCT Viread 33 mg/g granules
Danish: Indlægsseddel: Information til patienten Viread 33 mg/g granulat
English: After week 72, virologic suppression was maintained for those receiving double-blind tenofovir disoproxil followed by open-label tenofovir disoproxil (TDF-TDF group): 86.5% (45/52) of subjects in the TDF-TDF group had HBV DNA < 400 copies/ml at week 192.
Danish: Efter uge 72 blev virologisk suppression opretholdt hos de patienter, som fik dobbeltblindet tenofovirdisoproxil efterfulgt af open-label tenofovirdisoproxil (tenofovirdisoproxil-tenofovirdisoproxil-gruppen): 86,5% (45/52) af patienterne i tenofovirdisoproxiltenofovirdisoproxil-gruppen havde HBV-dna < 400 kopier/ml ved uge 192.
English: Viread 123 mg film-coated tablets are white, triangle-shaped, film-coated tablets, 8.5 mm in diameter, debossed on one side with “GSI” and on the other side with “150”.
Danish: Viread 123 mg filmovertrukne tabletter er hvide, trekantede, filmovertrukne tabletter, der måler 8,5 mm i diameter og er præget med „GSI“ på den ene side og „150“ på den anden side.
English: Table 4: Efficacy parameters in compensated HBeAg negative and HBeAg positive patients at week 48
Danish: Tabel 4: Virkningsparametre hos kompenserede HBeAg-negative og HBeAg-positive patienter i uge 48
English: Viread 123 mg tablets are not suitable for the following groups:
Danish: Viread 123 mg tabletter er ikke egnede til følgende grupper:
English: lactic acidosis Nervous system disorders: Very common:
Danish: Nervesystemet: Meget almindelig:
English: • For HIV, Viread 123 mg tablets are only suitable for children who have already been treated with other HIV medicines which are no longer fully effective due to development of resistance, or have caused side effects.
Danish: • Til hiv er Viread 123 mg tabletter kun egnede til børn, der allerede er blevet behandlet med anden hiv-medicin, der ikke længere er helt effektivt på grund af udvikling af resistens, eller der forårsagede bivirkninger.
English: Each tablet contains 137 mg lactose (as monohydrate).
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver tablet indeholder 137 mg lactose (som monohydrat).
English: If Viread 204 mg film-coated tablets are discontinued in patients co-infected with HIV and hepatitis B virus (HBV), these patients should be closely monitored for evidence of exacerbation of hepatitis (see section 4.4).
Danish: Hvis Viread 204 mg filmovertrukne tabletter seponeres hos patienter med samtidig hiv-infektion og hepatitis B-virus (HBV), skal disse patienter monitoreres tæt for tegn på eksacerbation af hepatitis (se pkt.
English: In a paediatric study (GS-US-174-0115), 52 patients (including 6 patients with lamivudine resistance mutations at baseline) initially received blinded tenofovir disoproxil for up to 72 weeks and then 51/52 patients switched to open-label tenofovir disoproxil (tenofovir disoproxil-tenofovir disoproxil group).
Danish: I et pædiatrisk studie (GS-US-174-0115) fik 52 patienter (herunder 6 patienter med lamivudinresistente mutationer ved baseline) indledningsvist blindet tenofovirdisoproxil i op til 72 uger, og derefter skiftede 51/52 patienter over til open-label tenofovirdisoproxil (tenofovirdisoproxil-tenofovirdisoproxil-gruppen).
English: • Talk to your doctor or pharmacist if you have had kidney disease or if tests have shown problems with your kidneys.
Danish: • Kontakt lægen eller apotekspersonalet, hvis De tidligere har haft nyresygdomme, eller hvis undersøgelser har vist, at De har nyreproblemer.
English: If Viread 163 mg film-coated tablets are discontinued in patients co-infected with HIV and hepatitis B virus (HBV), these patients should be closely monitored for evidence of exacerbation of hepatitis (see section 4.4).
Danish: Hvis Viread 163 mg filmovertrukne tabletter seponeres hos patienter med samtidig hiv-infektion og hepatitis B-virus (HBV), skal disse patienter monitoreres tæt for tegn på eksacerbation af hepatitis (se pkt.
English: Fifty-four patients (including 2 patients with lamivudine resistance mutations at baseline) initially received blinded placebo treatment for 72 weeks, and 52/54 patients followed with tenofovir disoproxil (PLB-TDF group).
Danish: 54 patienter (herunder 2 patienter med lamivudinresistente mutationer ved baseline) fik indledningsvist blindet placebobehandling i 72 uger, og 52/54 patienter fik derefter tenofovirdisoproxil (PLB-TDF-gruppen).
English: NAME OF THE MEDICINAL PRODUCT Viread 204 mg film-coated tablets
Danish: Indlægsseddel: Information til brugeren Viread 204 mg filmovertrukne tabletter
English: (log10 copies/ml)
Danish: (0,32 mmol/l).
English: Very common: dizziness Gastrointestinal disorders:
Danish: Meget almindelig: svimmelhed Mave-tarm-kanalen:
English: Tenofovir disoproxil 245 mg n = 176c
Danish: 245 mg tenofovirdisoproxil n = 176c
English: Bone Mineral Density (BMD) data from Study GS-US-174-0115 are summarized in Table 8:
Danish: Data vedrørende knoglemineraltæthed (BMD) fra studiet GS-US-174-0115 er opsummeret i tabel 8:
English: 288m 384o 96c 144f
Danish: 144e 192h 240j 288m 384o 96c 144f
English: Each level dosing scoop provides 1 g of the granules which contains 33 mg tenofovir disoproxil (as fumarate).
Danish: Hver strøget måleske giver 1 g granulat, der indeholder 33 mg tenofovirdisoproxil (som fumarat).
English: PHARMACEUTICAL FORM AND CONTENTS 60 g granules.
Danish: 60 g granulat.
English: Viread 123 mg film-coated tablets are indicated for the treatment of chronic hepatitis B in paediatric patients aged 6 to < 12 years who weigh from 17 kg to less than 22 kg, with:
Danish: Viread 123 mg filmovertrukne tabletter er indiceret til behandling af kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 17 kg og under 22 kg med:
English: Tenofovir disoproxil 245 mg n = 250c
Danish: 245 mg tenofovirdisoproxil n = 250c
English: White, triangle-shaped, film-coated tablets, 8.5 mm in diameter, debossed on one side with “GSI” and on the other side with “150”.
Danish: Hvide, trekantede, filmovertrukne tabletter, der måler 8,5 mm i diameter og er præget med „GSI“ på den ene side og „150“ på den anden.
English: Fifty-four patients (including 2 patients with lamivudine resistance mutations at baseline) initially received blinded placebo treatment for 72 weeks, and 52/54 patients followed with tenofovir disoproxil (PLB-tenofovir disoproxil group).
Danish: 54 patienter (herunder 2 patienter med lamivudinresistente mutationer ved baseline) fik indledningsvist blindet placebobehandling i 72 uger, og 52/54 patienter fik derefter tenofovirdisoproxil (PLB-tenofovirdisoproxil-gruppen).
English: Viread 245 mg film-coated tablets Tenofovir disoproxil
Danish: Viread 245 mg filmovertrukne tabletter Tenofovirdisoproxil
English: White, round-shaped, film-coated tablets, 10.7 mm in diameter, debossed on one side with “GSI” and on the other side with “200”.
Danish: Hvide, runde, filmovertrukne tabletter, der måler 10,7 mm diameter og er præget med „GSI“ på den ene side og „200“ på den anden.
English: Viread 204 mg film-coated tablets are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients, with NRTI resistance or toxicities precluding the use of first line agents, aged 6 to < 12 years who weigh from 28 kg to less than 35 kg.
Danish: Viread 204 mg filmovertrukne tabletter er indiceret i kombination med andre antiretrovirale lægemidler til behandling af hiv 1-inficerede, pædiatriske patienter med NRTI-resistens eller toksiciteter, der udelukker brugen af førstevalgsbehandling, i alderen 6 til < 12 år, der vejer mellem 28 kg og under 35 kg.
English: • HIV-1 infected children and adolescents aged 2 to less than 18 years who have already been treated with other HIV medicines which are no longer fully effective due to development of resistance, or have caused side effects
Danish: • Hiv-inficerede børn og unge i alderen 2 til under 18 år, som allerede er blevet behandlet med anden hiv-medicin, der ikke længere er helt effektivt på grund af udvikling af resistens, eller der forårsagede bivirkninger
English: Viread 245 mg film-coated tablets contain lactose monohydrate.
Danish: Viread 245 mg filmovertrukne tabletter indeholder lactosemonohydrat.
English: If Viread 123 mg film-coated tablets are discontinued in patients co-infected with HIV and hepatitis B virus (HBV), these patients should be closely monitored for evidence of exacerbation of hepatitis (see section 4.4).
Danish: Hvis Viread 123 mg filmovertrukne tabletter seponeres hos patienter med samtidig hiv-infektion og hepatitis B-virus (HBV), skal disse patienter monitoreres tæt for tegn på eksacerbation af hepatitis (se pkt.
English: Viread 204 mg tablets are a treatment for HIV (Human Immunodeficiency Virus) infection.
Danish: Viread 204 mg tabletter anvendes til behandling af infektion med hiv (humant immundefektvirus).
English: Viread 163 mg film-coated tablets are indicated for the treatment of chronic hepatitis B in paediatric patients aged 6 to < 12 years who weigh from 22 kg to less than 28 kg, with:
Danish: Viread 163 mg filmovertrukne tabletter er indiceret til behandling af kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år, der vejer mellem 22 kg og under 28 kg med:
English: Viread 163 mg film-coated tablets are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients, with NRTI resistance or toxicities precluding the use of first line agents, aged 6 to < 12 years who weigh from 22 kg to less than 28 kg.
Danish: Viread 163 mg filmovertrukne tabletter er indiceret i kombination med andre antiretrovirale lægemidler til behandling af hiv 1-inficerede, pædiatriske patienter med NRTI-resistens eller toksiciteter, der udelukker brugen af førstevalgsbehandling, i alderen 6 til < 12 år, der vejer mellem 22 kg og under 28 kg.
English: Viread 163 mg film-coated tablets Tenofovir disoproxil
Danish: Viread 163 mg filmovertrukne tabletter Tenofovirdisoproxil
English: Chronic hepatitis B: Steady-state tenofovir exposure in HBV infected adolescent patients (12 to < 18 years of age) receiving an oral daily dose of tenofovir disoproxil 245 mg was similar to exposures achieved in adults receiving once-daily doses of tenofovir disoproxil 245 mg .
Danish: Kronisk hepatitis B: Steady-state tenofovir-eksponering hos HBV-inficerede unge patienter (i alderen 12 til <18 år) i behandling med en oral, daglig dosis tenofovirdisoproxil på 245 mg var sammenlignelig med eksponeringer opnået hos voksne i behandling med tenofovirdisoproxil 245 mg en gang dagligt.
English: Don't stop taking Viread without your doctor's advice.
Danish: De må ikke holde op med at tage Viread, medmindre Deres læge har anbefalet det.
English: Among the subjects who received placebo during the double-blind period, the proportion of subjects with HBV DNA < 400 copies/mL rose sharply after they began treatment with open-label tenofovir disoproxil (PLB-tenofovir disoproxil group): 74.1% (40/54) of subjects in the PLB-tenofovir disoproxil group had HBV DNA < 400 copies/ml at week 192.
Danish: Blandt de patienter, som fik placebo i den dobbeltblinde periode, steg andelen af patienter med HBV-dna < 400 kopier/ml skarpt efter påbegyndelse af behandling med open-label tenofovirdisoproxil (PLB-tenofovirdisoproxil-gruppen): 74,1% (40/54) af patienterne i PLB-tenofovirdisoproxil-gruppen havde HBV-dna < 400 kopier/ml ved uge 192.
English: Viread is also available as granules for the treatment of HIV-1 infection and chronic hepatitis B in paediatric patients aged 2 to < 12 years and as reduced tablet strengths for the treatment of
Danish: Viread fås også som granulat til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 2 til < 12 år og i reducerede tabletstyrker til behandling af hiv 1-infektion og kronisk hepatitis B hos pædiatriske patienter i alderen 6 til < 12 år (se pkt.
English: Tenofovir disoproxil Renal and urinary disorders: Uncommon:
Danish: Nyrer og urinveje: Ikke almindelig:
English: Viread 245 mg film-coated tablets are supplied in bottles containing 30 tablets.
Danish: Viread 245 mg filmovertrukne tabletter leveres i tabletbeholdere, der indeholder 30 tabletter.
English: INFORMATION IN BRAILLE Viread 163 mg [Outer packaging only]
Danish: Viread 163 mg [kun på den ydre emballage
English: f 48 weeks of double-blind adefovir dipivoxil followed by 96 weeks open-label tenofovir disoproxil.
Danish: f 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 96 uger open-label tenofovirdisoproxil.
English: Gastrointestinal disorders: Very common:
Danish: svimmelhed Mave-tarm-kanalen: Meget almindelig:
English: LIST OF EXCIPIENTS Contains lactose monohydrate.
Danish: Indeholder lactosemonohydrat.
English: NAME OF THE MEDICINAL PRODUCT Viread 163 mg film-coated tablets
Danish: Indlægsseddel: Information til brugeren Viread 163 mg filmovertrukne tabletter
English: Viread 163 mg film-coated tablets contain lactose monohydrate.
Danish: Viread 163 mg filmovertrukne tabletter indeholder lactosemonohydrat.